PK and PD Study of NPI-001 and Cysteamine Bitartrate
PK and PD Study of NPI-001 and Cysteamine Bitartrate
Active, not recruiting · NCT05994534 · Registry updated 2026-06-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PK and PD Study of NPI-001 and Cysteamine Bitartrate | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, cystinosis, hereditary disease, inborn errors of metabolism, lysosomal storage disease, metabolic disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-30 | NCT05994534 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nacuity Pharmaceuticals, Inc. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital at Westmead | Westmead | Australia | 9 |